Patent Assignment
Reel/Frame 023390/0220
Security Agreement
Recorded: 2009-10-19
Received: 2009-10-19
Pages: 9
Assignor
ENDO PHARMACEUTICALS SOLUTIONS INC.
Executed: 2009-10-16
Assignee
JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
10 SOUTH DEARBORN, CHICAGO, IL, 60603, UNITED STATES
Covered Properties
(28)
An Implantable Device for the Sustained Release of a Polypeptide
Application:
12/490,971 →
Octreotide Implant Having a Release Agent and Uses Thereof
Application:
12/490,979 →
Implantation Device for Subcutaneous Implatation of an Object Under the Skin
Application:
12/415,681 →
Combination Treatment for Bladder Cancer
Application:
12/397,831 →
Sulfonic Acid and Aldehyde Condensation Polymers for the Treatment and Prevention of Hpv
Application:
12/393,778 →
Implantable Device for the Delivery of Naltrexone and Methods of Use Thereof
Application:
12/351,617 →
Compositions and Methods for the Treatment of Bladder Cancer
Application:
12/324,019 →
Implantable Device for the Delivery of Risperidone and Methods of Use Thereof
Application:
61/117,448 →
Implantable Device for the Delivery of Histrelin and Methods of Use Thereof
Application:
61/101,551 →
Implantable Device for the Delivery of Octreotide and Methods of Use Thereof
Application:
61/101,552 →
Implantable Device for the Delivery of Risperidone and Methods of Use Thereof
Application:
61/101,548 →
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Application:
12/242,497 →
Controlled Release Formulations of Octreotide
Application:
12/240,690 →
Delivery of Dry Formulations of Octreotide
Application:
12/171,999 →
Implant Device Release Agents and Methods of Using Same
Application:
12/109,852 →
Method of Inserting an Object Under the Skin
Application:
11/531,311 →
Method for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2-Oxo-Hexyl)-1-Isoindolinone)
Application:
11/411,952 →
Controlled Release Formulations of Octreotide
Application:
11/372,749 →
Use of Pagoclone for the Treatment of Social Anxiety Disorder
Application:
11/352,286 →
Methods for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2OXO-Hexyl)-1-Isoidolinone
Application:
11/206,144 →
Compositions and Methods for Treating Precocious Puberty
Application:
11/155,822 →
Methods and Compositions for Alleviating Stuttering
Application:
11/046,706 →
Long Term Drug Delivery Devices with Polyurethane Based Polymers and Their Manufacture
Application:
10/915,625 →
Implanting Device
Application:
29/179,382 →
Implanting Device and Method of Using Same
Application:
10/406,397 →
Methods for Making 2-(7-Chloro-1,8-Naphthyridine-2-Yl)-3-(5-Methyl-2-Oxo-Hexyl)-1-Isoindolinone
Application:
10/400,780 →
Binding Apparatus
Application:
10/149,925 →
Methods of Treating Obsessive-Compulsive Disorder
Application:
10/133,471 →